In the original article, the Ethics Statement was incomplete as it only included the name of one of the institutions. The corrected statement appears below.

Ethics Statement {#s1}
================

The studies involving human participants were reviewed and approved by Ethic committee Istituto Ortopedico Rizzoli IRCCS, Regina Elena National Cancer Institute IRCCS, Bambino Gesù Children\'s Hospital IRCCS and by the proper institutional review boards of the CRO Aviano IRCCS National Cancer Institute, Veneto Institute of Oncology (IOV) IRCCS, University of Padua, Candiolo Cancer Institute FPO-IRCCS, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) Meldola IRCCS, Istituto Nazionale dei Tumori di Milano Fondazione IRCCS. Written informed consent to participate in this study was provided by the participants\' legal guardian/next of kin.

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

[^1]: Approved by: Frontiers Editorial Office, Frontiers Media SA, Switzerland

[^2]: This article was submitted to Cancer Molecular Targets and Therapeutics, a section of the journal Frontiers in Oncology

[^3]: †These authors have contributed equally to this work and share first authorship

[^4]: ‡These authors share last authorship
